Search Results

139 Results for "biovie".

Sort By

Press Releases

BioVie’s Upcoming Parkinson’s Disease Clinical Trial is Fully Funded

November 5, 2024
·
4 min read
BioMidwest

Join BioVie’s Exclusive Live Investor Webinar and Q&A Session on June 26

BioVie Inc. is pleased to invite investors to a webinar on June 26, 2024, at 4:15 p.m. ET.

June 12, 2024
·
3 min read
Press Releases

Join BioVie’s Exclusive Live Investor Webinar and Q&A Session on November 7th, 2024

October 24, 2024
·
4 min read
Press Releases

BioVie Inc. Announces Closing of Registered Direct Offering

October 30, 2024
·
4 min read
Press Releases

BioVie Inc. Announces Closing of Public Offering

September 26, 2024
·
4 min read
Press Releases

BioVie Inc. Announces Proposed Public Offering

September 24, 2024
·
5 min read
Press Releases

BioVie Inc. Announces Pricing of Public Offering

September 24, 2024
·
5 min read
BioMidwest

BioVie’s Bezisterim Demonstrates Potential Improvements in Sleep/Fatigue and Restless Leg Symptoms for Parkinson’s Disease Patients

BioVie Inc. announced data from an oral presentation made yesterday at the XXIX World Congress on Parkinson’s Disease and Related Disorders hosted by the International Association of Parkinsonism and Related Disorders and held May 19-22, 2024 in Lisbon, Portugal.

May 22, 2024
·
6 min read
Drug Development

BioVie Announces Formation of Advisory Board for Bezisterim in Long COVID

BioVie Inc. today announced the formation of a long COVID Advisory Board that will provide the Company with strategic guidance on the design and execution of a Phase 2b trial in patients with long COVID.

June 4, 2024
·
12 min read
Press Releases

BioVie Inc. Announces Closing of Registered Direct Offering and Concurrent Private Placement

October 23, 2024
·
5 min read